ABEO vs TXT · rev $20.1M vs P/E 19, rev $7.52B
Abeona Therapeutics Inc (ABEO) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported ABEO revenue for 2026-06-30 was $20.1M. Net income was -$37.3M. ABEO currently screens at market cap $301.8M.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
ABEO currently screens at market cap $301.8M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the ABEO and TXT stock pages for the full models.
Not investment advice.